Medicine and Dentistry
Antiarrhythmic Agent
9%
Anticoagulation
5%
Apoplexy
9%
Atrial Fibrillation
100%
Atrial Fibrillation Ablation
6%
Cardiac Dysrhythmia
6%
Cardiovascular System
9%
Catheter Ablation
53%
Catheter Ablation
8%
Hazard Ratio
5%
Heart Atrium Arrhythmia
5%
Heart Failure
16%
Idiopathic Ventricular Fibrillation
7%
Implantable Automatic Defibrillator
9%
Paroxysmal Atrial Fibrillation
18%
Persistent Atrial Fibrillation
14%
Phrenic Nerve
5%
Pulmonary Vein
10%
Pulmonary Vein Isolation
37%
Quality of Life
5%
Rapid Amplification of cDNA Ends
10%
Recurrent Disease
14%
Sex Difference
9%
Keyphrases
Ablation
6%
Atrial Fibrillation
49%
Atrial Fibrillation Ablation
15%
Beta-blockers
5%
Clinical Outcomes
6%
Confidence Interval
9%
Cryoballoon Pulmonary Vein Isolation
7%
Digoxin
5%
Dutch
5%
Hazard Ratio
7%
Heart Failure
18%
Heart Failure with Preserved Ejection Fraction (HFpEF)
8%
Implantable Cardioverter-defibrillator Shock
8%
Incident Atrial Fibrillation
8%
Meta-analysis
7%
Patients with Heart Failure
8%
Persistent Atrial Fibrillation
9%
Pulmonary Vein Isolation
14%
Pulsed Field Ablation
21%
Quality of Life
5%
Rate Control
7%
Redo Surgery
6%
Risk Factors
5%
Secondary Prevention
7%
Sex Differences
8%
Sex-related Differences
7%
Sinus Rhythm
9%
Sudden Cardiac Death Prevention
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antiarrhythmic Agent
14%
Atrial Fibrillation
57%
Congenital Heart Disease
5%
Heart Arrhythmia
5%
Heart Failure
28%
Heart Failure with Reduced Ejection Fraction
7%
Heart Ventricle Arrhythmia
8%
Paroxysmal Atrial Fibrillation
8%
Permanent Atrial Fibrillation
7%
Persistent Atrial Fibrillation
8%
Recurrent Disease
10%
Sudden Cardiac Death
5%
Symptom
5%
